A-3 Request for Quotations NAD

Department of War
Defense Health Agency
Pharmacy and Therapeutics Committee Uniform Formulary
Request for Quotation
Part

Description
Introduction
Instructions and Notices
Uniform Formulary Considerations and Evaluation Criteria Government Furnished Information
Definitions and Acronyms
Appendix 1: Manufacturer Quote Submission Checklist
Appendix 2: Uniform Formulary Blanket Purchase Agreement (UF BPA) Appendix 3: Uniform Formulary Additional Discount Program (UF ADP) Appendix 4: NDC Price List
Part 1 - Introduction

1.1. The Department of War (DOW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS). The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DOW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DOW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). A pharmaceutical agent is a legend FDA-approved drug that is intended for self-administration by the patient in the outpatient setting that are part of the TRICARE pharmacy benefit. Prior to the scheduled P&T Committee review of specified pharmaceutical agents or classes, manufacturers have an opportunity to submit offers that reduce DOW cost of an agent for consideration by the P&T Committee. This process is described herein.

"This proposal contains trade secret and confidential business or financial information exempt from disclosure under the Freedom of Information Act. This quotation includes data that shall not be disclosed outside the Government and shall not be duplicated, used, or disclosed—in whole or in part—for any purpose other than to evaluate this quotation. If a contract is awarded to this quoter as a result of—or in connection with—the submission of this data, the Government shall have the right to duplicate, use, or disclose the data to the extent provided in the resulting contract. This restriction does not limit the Government's right to use information contained in the data if it is obtained from another source without restriction. The data subject to this restriction are contained in all attached pricing sheets.”